TD SYNNEX (SNX) director Hume exercises 18,365 options and sells stock
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TD SYNNEX director Richard T. Hume reported an option exercise and related share sales. On February 2, 2026, he exercised 18,365 employee stock options at an exercise price of $107.32 per share, receiving the same number of TD SYNNEX common shares.
That day he sold several blocks of common stock in open-market transactions under a Rule 10b5-1 trading plan adopted on July 14, 2025. Reported weighted-average sale prices included $157.66, $158.58, $159.64, $160.55, and $161.18 per share. Following these transactions, Hume directly owned 42,515 TD SYNNEX shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 23,365 shares ($3,753,017)
Net Sell
7 txns
Insider
HUME RICHARD T
Role
Director
Sold
23,365 shs ($3.75M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 18,365 | $0.00 | -- |
| Exercise | Common Stock | 18,365 | $107.32 | $1.97M |
| Sale | Common Stock | 216 | $157.66 | $34K |
| Sale | Common Stock | 236 | $158.58 | $37K |
| Sale | Common Stock | 527 | $159.64 | $84K |
| Sale | Common Stock | 17,093 | $160.55 | $2.74M |
| Sale | Common Stock | 5,293 | $161.18 | $853K |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 65,880 shares (Direct)
Footnotes (1)
- The stock option exercises and sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025. Represents the weighted average sales price for a number of transactions effected at prices ranging from $157.115 to $157.995. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $158.365 to $158.88. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $159.07 to $159.955. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.00 to $160.995. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $161.00 to $161.51. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. This stock option is fully vested.
FAQ
What insider transaction did TD SYNNEX (SNX) disclose for Richard T. Hume?
TD SYNNEX director Richard T. Hume exercised 18,365 employee stock options and sold common shares on February 2, 2026. The transactions converted options into stock and then sold portions of those shares in the open market, as reflected in his updated share holdings.
How many TD SYNNEX (SNX) options did Richard T. Hume exercise?
Richard T. Hume exercised 18,365 employee stock options on February 2, 2026. Each option entitled him to buy one TD SYNNEX common share at an exercise price of $107.32, resulting in 18,365 newly acquired shares before any subsequent sales that same day.
Was the TD SYNNEX (SNX) insider sale under a Rule 10b5-1 plan?
Yes. The stock option exercises and related sales were carried out under a Rule 10b5-1 trading plan adopted by Richard T. Hume on July 14, 2025. Such plans pre-schedule trades, helping separate them from day-to-day discretionary trading decisions.
What does the Form 4 say about Richard T. Hume’s TD SYNNEX (SNX) stock options?
The Form 4 shows an employee stock option with an exercise price of $107.32 for 18,365 shares of TD SYNNEX common stock. The filing notes this option is fully vested, and following the February 2, 2026 exercise, no derivative securities remained beneficially owned.